Question: GMP-compliant expansion protocols for hematopoietic stem cells ex vivo
Aryl hydrocarbon receptor antagonist vs. HDAC inhibitor for HSPC expansion
Collecting findings
0/3 publication-ready
Findings metrics
—
total
—
verified
—
pending
—
rejected